help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendlewicz, J.
Right arrow Articles by Van Cauter, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendlewicz, J.
Right arrow Articles by Van Cauter, E.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 3 856-862
Copyright © 1999 by The Endocrine Society


Original Studies

Genetic Control of 24-Hour Growth Hormone Secretion in Man: A Twin Study1

Julien Mendlewicz, Paul Linkowski, Myriam Kerkhofs, Rachel Leproult, Georges Copinschi and Eve Van Cauter

Department of Psychiatry and Sleep Laboratory, Erasme Hospital (J.M., P.L., M.K.), Center for the Study of Biological Rhythms (R.L., G.C.), Laboratory of Experimental Medicine (G.C.), Université Libre de Bruxelles, B-1070 Brussels, Belgium; and the Department of Medicine, University of Chicago (E.V.C.), Chicago, Illinois 60637

Address all correspondence and requests for reprints to: Julien Mendlewicz, M.D., Ph.D., Department of Psychiatry, Erasme Hospital, Université Libre de Bruxelles, 808 route de Lennik, B-1070 Brussels, Belgium. E-mail: jmendlew{at}ulb.ac.be


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The aim of this study was to delineate the contributions of genetic and environmental factors in the regulation of the 24-h GH secretion. The 24-h profile of plasma GH was obtained at 15-min intervals in 10 pairs of monozygotic and 9 pairs of dizygotic normal male twins, aged 16–34 yr. Sleep was polygraphically monitored. Significant pulses of GH secretion were identified using a modification of the computer algorithm ULTRA. For each significant pulse, the amount of GH secreted was calculated by deconvolution. A procedure specially developed for twin studies was used to partition the variance of investigated parameters into genetic and environmental contributions. A major genetic effect was evidenced on GH secretion during wakefulness (with a heritability estimate of 0.74) and, to a lesser extent, on the 24-h GH secretion. Significant genetic influences were also identified for slow wave sleep and height. These data demonstrate that human GH secretion in young adulthood is markedly dependent on genetic factors.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
GH IS RELEASED in a pulsatile fashion from the anterior pituitary under a complex regulatory mechanism involving stimulation by hypothalamic GHRH and inhibition by hypothalamic somatostatin (1). In addition, recent evidence indicates that GH secretion is also under the control of an as yet unidentified stimulatory pathway that may be activated by synthetic compounds such as the GH-releasing peptides and their functional agonists (2). The 24-h profile of GH secretion in normal young adults consists of low levels abruptly interrupted by large secretory pulses. The major secretory pulse usually occurs shortly after sleep onset in temporal association with slow wave (SW) sleep (3, 4, 5). Sleep-related GH secretion appears to be less sensitive to somatostatin inhibition than daytime secretion, suggesting that distinct mechanisms could underlie GH secretion during waking and sleep (6).

In recent years, growing interest has focused on the importance of genetic factors in the regulation of neuroendocrine systems (7, 8), but few studies are available on the genetic regulation of the somatotropic axis (9, 10, 11). Recent molecular studies have localized the human GH gene cluster on chromosome 17 (12) and identified the human GHRH receptor gene (13). Several genetic syndromes relating short stature and GH insufficiency have been described (14). GH has a major effect on height, and the estimated heritability of height reaches 92% (10).

The present study was designed to determine the relative contributions of genetic and nongenetic factors on individual differences in GH secretion during waking and sleep. The 24-h profile of plasma GH was obtained at 15-min intervals in a sample of 10 monozygotic and 9 dizygotic twin pairs. Sleep was polygraphically monitored, and pulsatile GH secretion was estimated by mathematical deconvolution. A statistical method specifically designed for the analysis of twin studies was used for the identification of genetic and environmental influences on GH secretion and sleep.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

Male twins were selected from the Twin Register of the University of Antwerp (Antwerp, Belgium) and the Twin Register of the Vrije Universiteit Brussel (Brussels, Belgium) after a careful medical evaluation. Criteria for eligibility included normal health and the absence of personal or family history of endocrine or psychiatric disorder. As GH secretion is markedly influenced by sleep (3, 4, 5), only subjects with regular sleep-wake schedules and absence of sleep complaints were included. Twin pairs in which one member was taking drugs, was a shift worker, or had traveled across time zones during the past 3 months were excluded. The protocol was approved by the institutional review board. Informed consent was obtained from all subjects and from their parents if they were under 18 yr of age. The volunteers were paid for their participation in the study. The twins were classified as mono- (MZ) and dizygotic (DZ) after analysis of different genetic markers, including HLA and ABO, Rh, MnSs, Kk, Lea, Leb, Fya, Fyb, Jka, Jkb, and P1 blood groups. Other details of subject recruitment have been previously reported (8, 15).

A total of 10 MZ pairs (aged 16–30 yr; mean, 21.4 yr) and 9 DZ pairs (aged 20–34 yr; mean, 25.2 yr) were included in the present study. All subjects had reached stage Tanner V of sexual development. In the MZ group, 8 of the 10 twin pairs were living together. In the DZ group, 4 of the 9 twin pairs were cohabiting. All subjects were living in the same geographical area (within a 50-km radius from the investigation center).

Experimental protocol

All investigations were performed in the Sleep Laboratory of the Department of Psychiatry, Erasme Hospital, Université Libre de Bruxelles (Brussels, Belgium). Both members of each pair were studied simultaneously in separate rooms located in the immediate vicinity of each other. On admission, all subjects had a physical examination, including measurements of body weight and height, and routine laboratory tests. All were found to be in normal health. After 1 night of habituation, sleep was polygraphically recorded during 4 consecutive nights. On the day preceding the last night of recording, a catheter was inserted into a forearm vein between 1200–1400 h. Blood sampling for GH determinations was started 1 h after catheter insertion, and blood samples were obtained at 15-min intervals for 25 h. Data collected during the first hour of sampling were discarded to avoid artifactual effects related to the venipuncture stress. During the night, the catheter was connected to plastic tubing extending into an adjacent room, and sampling was thus performed without disturbing the subject. The iv line was kept patent with a slow drip (10 mL/h) of heparinized saline (750 IU heparin in 0.9 g NaCl/dL). All subjects were ambulatory during the day and were fed the standard hospital diet (breakfast at 0800 h, lunch at 1230 h, dinner at 1900 h). Daytime naps were prevented. The subjects were asked to retire around 2230 h and were allowed to wake up spontaneously in the morning. During bedtime hours, the lights were turned off.

GH assay

Duplicate determinations of plasma GH concentrations were performed using a polyclonal antibody RIA with a lower limit of sensitivity of 0.4 µg/mL (16). All samples from the same twin pair were analyzed in the same assay. The intraassay coefficient of variation averaged 9% in the range 0.4–2.0 µg/L, 6% in the range 2.0–5.0 µg/L, and 5% above 5.0 µg/L. The interassay coefficient of variation averaged 15%.

Determination of GH secretory rates

Significant pulses of GH secretion were identified using a modification of the computer algorithm ULTRA (17). The threshold for significance of a pulse was set at twice the intraassay coefficient of variation in the relevant concentration range. For each significant pulse, the amount of GH secreted was calculated by deconvolution based on a one-compartment model for GH clearance and variable individual half-lives, as previously described (5). The half-life was adjusted for each pair of subjects in the previously reported physiological range of 15–21 min (18) by an iterative process designed to minimize the number of negative secretory rates. On the average, the half-disappearance time was 18.4 ± 2.3 min (mean ± SD). A volume of distribution of 7% of body weight was used in these calculations. The SD of the error associated with each estimated secretory rate was calculated following the theory of error propagation and under the assumption of normally distributed errors on plasma levels. The duration of a secretory pulse was defined as the time interval separating the preceding and following troughs. In each individual profile, the level of baseline secretion was estimated as the secretory rate necessary to maintain the baseline GH concentrations during the interpulse intervals. For each significant pulse, pulsatile GH secretion was calculated by subtracting the baseline secretion from the total secretion. The amount of pulsatile GH secretion over a given time interval was determined by summing the amounts of pulsatile secretion in each of the significant pulses occurring during that time interval. If a pulse overlapped two time intervals, the amount of GH secreted was divided proportionally.

Sleep recording and analysis

The polygraphic recordings of sleep were visually scored at 20-s intervals in stages wake, I, II, III, IV, and rapid eye movement (REM) according to standardized criteria (19). Sleep onset and morning awakening were defined, respectively, as the first and last 20-s intervals, scored II, III, IV, or REM. The sleep period was defined as the time interval separating sleep onset from morning awakening. SW stages were defined as the sum of stages III and IV. The twins included in the present study were a subset of a larger sample of 26 pairs of twins for whom a detailed analysis of genetic effects on sleep parameters has been previously reported (15). As in adult normal men, nocturnal GH secretion is influenced strongly by sleep, we repeated for the subset of subjects included in the present study the analysis of genetic effects for the durations of stages wake, I+II, III+IV (SW sleep), and REM.

Statistical analysis of genetic variance

The twin values for each of the analyzed parameters were submitted to the TWINAN method for analysis of twin data developed by Christian et al. (20, 21, 22, 23). This method is applicable only if mean values for the investigated parameter are not significantly different between MZ and DZ twins. Therefore, for each parameter, possible differences between both groups were tested using a two-tailed unpaired t test. When applied to small twin samples such as those in the present study, this analysis is relatively sensitive to outlying values. Therefore, for each parameter, the outlying values were identified using a two-tailed test (24, 25) with a significance level of 0.05. When a significant outlier(s) was identified, the analysis was repeated after excluding the outlying pair(s). A genetic effect on the variability of a given parameter was considered significant if the appropriate estimate of genetic variance was significant (P < 0.05) and if the result was not critically dependent on the inclusion of significant outlier(s).

Possible differences in the MZ/DZ variances of each parameter were tested using an F test for significance of differences. When the variances were similar in both groups, as indicated by an arbitrary cut-off significance level of F test with P > 0.20, the within-pair estimate of genetic variance (GWT) was calculated according to the formula GWT = MWDZ - MWMZ, with MWDZ and MWMZ being the mean squares for within-pair variation in DZ and MZ twins, respectively. The significance of GWT was tested by a one-tailed F = MWDZ/MWMZ. As this estimate may be biased if the variances in the MZ and DZ groups are not similar, another estimate, the among-component estimate of genetic variance GCT, was used when the F test had a P < 0.20, according to the formula GCT = (GWT + GAT)/2, with GAT = MAMZ - MADZ, MAMZ and MADZ being the mean squares for among-pair variation in MZ and DZ twins, respectively. The significance of GCT was tested by a two-tailed F' = (MAMZ + MWDZ)/(MADZ + MWMZ).

Among the outputs of the TWINAN analysis are the intraclass correlation coefficients, which estimate for the investigated parameter the similarity in the MZ and DZ twin pairs. The existence of a significant genetic effect is reflected typically in significant intraclass correlations in both the MZ and DZ groups, with a higher intraclass correlation in the MZ than in the DZ group. If, however, the intraclass correlation is significant in the MZ group but not in the DZ group, the existence of a higher environmental covariance in the MZ group, rather than of a genetic effect, could be suspected, because a genetic effect should be reflected in a significant level of correlation among the DZ twins, who are related genetically as siblings. It is also possible that relatively small DZ intraclass correlations may reflect the presence of gene interactions (22, 26). To examine the first possibility, the TWINAN method includes a test to exclude the existence of a MZ-DZ difference in environmental covariance. In the present study, differences in environmental covariance could be associated with the higher proportion of twins living together in the MZ group. Therefore, a two-factor ANOVA of the within-pair differences in the parameter under consideration, using zygosity and cohabitational status (i.e. living together or not) as cofactors, was also performed.

When a significant genetic effect was evidenced, the heritability estimate was calculated according to the formula: heritability = (intraclass correlation coefficient for MZ twins - intraclass correlation coefficient for DZ twins) x 2.

Unless otherwise indicated, all group values are reported as the mean ± SEM.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Group values for anthropometric, GH, and sleep data in MZ and DZ twin pairs are shown in Table 1Go. DZ twins were slightly, but significantly, older than MZ twins, and their body mass indexes (BMIs) was significantly higher. Therefore, possible effects of age and BMI on the various GH and sleep parameters were tested. As expected, the duration of SW sleep was inversely related to age (P < 0.03), and all GH parameters were inversely related to both age and BMI (P < 0.10 at least). Therefore, GH values were adjusted by multiple linear regression analysis for the effect of age and BMI, and SW sleep values were adjusted by simple linear regression analysis for the effect of age. For all these parameters, the TWINAN analysis was repeated on adjusted data, and a genetic effect was considered significant if both the initial analysis of original data and the repeated analysis of adjusted data yielded consistently significant results.


View this table:
[in this window]
[in a new window]
 
Table 1. Anthropometric, GH, and sleep parameters in MZ and DZ twins

 
Each sleep and anthropometric parameter as well as each parameter quantifying GH secretion were submitted individually to the TWINAN analysis. For none of the parameters investigated was the within-pair reproducibility significantly higher in twins living together than in twins living apart.

GH secretion

All individual GH profiles exhibited the typical pattern of normal young men, with stable low levels abruptly interrupted by secretory pulses (5). As expected (5), a sleep-onset pulse associated with the first phase of SW sleep was present in all but one profile and constituted in most cases the major secretory episode. Overall, nearly two thirds of the total 24-h GH secretion occurred during the sleep period, which lasted, on the average, 7 h and 50 min. However, no significant relationship was observed between the individual amounts of sleep GH secretion and corresponding durations of SW sleep.

Representative 24-h plasma GH profiles in two MZ and two DZ twin pairs are shown in Fig. 1Go. Visual examination suggests a greater similarity of those profiles in MZ than in DZ twins during the wake period and, to a lesser extent, during the sleep period. A summary of the results of the genetic variance analysis is given in Table 2Go.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 1. Twenty-four-hour profiles of plasma GH in representative pairs of MZ and DZ twins. Black bar, Sleep period, as determined by polygraphic recording. Note the similarity of GH patterns in MZ, but not DZ, twins.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Summary of analysis of genetic variance

 
The pulsatile secretion during sleep averaged 354 ± 38 µg in MZ twins and 403 ± 81 µg in DZ twins (P = NS). The distribution of individual values of pulsatile sleep GH secretion around the line of identity is shown for both groups in Fig. 2Go (bottom). A significant difference in variance between the two groups was present (P = 0.02), primarily because of the contribution of a single 24-yr-old twin pair with very high values in the DZ sample. This pair failed to meet our criteria of significance for outlying values. When the entire sample was analyzed, the intraclass coefficients of correlation were high and similar in both groups (0.76 in MZ twins, 0.69 in DZ twins), and the applicable estimate of genetic variance did not provide evidence for a genetic effect (P = 0.94). Similar results were obtained after adjustment of GH values for the effects of age and BMI (P = 0.94). Although these results would suggest that GH secretion during sleep is more dependent on environmental than genetic factors, caution must be exerted because this conclusion rests entirely on the inclusion of the single DZ twin pair with unusually higher sleep-associated GH secretion. Indeed, when this pair is excluded, the difference in variance becomes nonsignificant (albeit with a probability level of 0.14, i.e. lower than the arbitrary cut-off point of 0.20), the intraclass coefficients of correlations are 0.76 in MZ twins and 0.55 in DZ twins, and the within-pair estimate of genetic variance is significant (P < 0.025). In view of these considerations, the present data do not allow exclusion of a genetic influence on GH secretion during the sleep period.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Scatter plots of individual amounts of GH secretion during the wake period (top panels) and during sleep (lower panels) in MZ and DZ twins. Solid lines represent lines of identity.

 
During the wake period, the pulsatile GH secretion averaged 222 ± 47 µg in MZ twins and 206 ± 45 µg in DZ twins (P = NS). The distribution of individual values of pulsatile GH secretion during the wake period around the line of identity is shown for both groups in Fig. 2Go (top). The variances were similar in both groups, and no outlier was detected. The intraclass coefficient of correlation was higher in MZ twins (0.87) than in DZ twins (0.50). The estimate of genetic variance was significant (P < 0.05), and the heritability estimate reached 0.74. The possibility of MZ-DZ differences in environmental covariance could be excluded at a P = 0.06 level. Similar conclusions were reached after adjustment of GH values for the effects of age and BMI (genetic variance significant at P = 0.09; heritability estimate of 0.67). Thus, the present data provide consistent evidence for a major genetic influence on daytime GH secretion.

The 24-h pulsatile GH secretion was similar in MZ and DZ twins (573 ± 77 vs. 610 ± 98 µg; P = NS). The variances were similar in both groups, and no outlier was detected. The intraclass coefficient of correlation was somewhat higher in MZ twins (0.87) than in DZ twins (0.74), and the estimate of genetic variance was significant (P = 0.05), but the heritability estimate was only 0.27. The possibility of MZ-DZ differences in environmental covariance could be excluded (P < 0.005). Similar conclusions were reached after adjustment of GH values for the effects of age and BMI (genetic variance significant at P = 0.09; heritability estimate of 0.18). Thus, those data indicate that the 24-h GH secretion is partially influenced by genetic factors.

Sleep parameters

For all sleep parameters, mean group values were similar in MZ and DZ twins (Table 1Go). The results of the analysis of genetic variance are given in Table 2Go. No significant outlier was detected for any of the sleep parameters except for the duration of wake stages. Neither genetic nor environmental effects could be evidenced for stages wake, I and II, or REM. A significant genetic effect was found for the duration of stages III and IV (SW sleep), with a higher intraclass coefficient of correlation in MZ twins (0.81) than in DZ twins (0.43), an estimated genetic variance significant at P < 0.03, and a heritability estimate of 0.76. The possibility of MZ-DZ differences in environmental covariance could be excluded at a P < 0.10 level. Similar conclusions were reached after adjustment of SW values for age (genetic variance significant at P < 0.02; heritability estimate of 0.91).

Anthropometric parameters

Differences in mean weight and height values were not significant (Table 1Go). The results of genetic variance analysis are shown in Table 2Go. No significant outlier was detected.

For weight, the variances were similar in both groups. The estimate of genetic variance was close to significance (P = 0.08), with a heritability estimate of 0.66, and the possibility of a difference in environmental covariance could be excluded (P = 0.04), indicating that weight is partially influenced by genetic factors.

For height, the intraclass coefficient of correlation was markedly higher in MZ twins than in DZ twins (0.96 vs. 0.48), the estimated genetic variance was significant at P < 0.01, and the heritability estimate reached 0.96. The possibility of a difference in environmental covariance could be excluded at a P = 0.07 level.


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
In the present study, the analysis of 24-h GH secretory profiles calculated from plasma concentrations measured at 15-min intervals in MZ and DZ twins permitted the demonstration that genetic influences play a significant role in determining the daily 24-h GH secretory output in young men. The impact of genetic factors was clearly dominant during the waking period, with a high heritability estimate of 74%. Whether nongenetic factors may play a more important role during sleep than during the wake period could not be determined. Variable sleep quality may constitute an additional contribution to environmental variability, decreasing the ability to detect a genetic effect in a small sample size such as that included in the present study. The present analysis also confirms the importance of genetic factors in the determination of height (10) and in the regulation of SW sleep (8, 15).

The existence of a possible genetic determination of GH release patterns was first suggested in 1974 by Parker and Rossman (9), who observed an apparent similarity in plasma 24-h GH profiles in one pair of identical twins, but not in dizygotic twins. Indirect evidence consistent with a genetic influence on GH secretion has been reported. Using twin studies, a genetic component has been demonstrated on circulating levels of insulin-like growth factor I (IGF-I) (10, 11, 27), which are GH dependent (28), and on height (10), which is strongly correlated with IGF-I levels (27). Genetic studies have identified the GHRH receptor gene (13), the GH gene cluster (12), and the IGF-I gene (29), and genetic syndromes relating short stature and growth hormone insufficiency have been described (14). Interestingly, we have recently shown that daytime secretion of PRL, a member of the PRL-GH gene family (30), is also under partial genetic control (31).

The high estimated heritability evidenced in the present study for wake GH secretion in young adults is consistent with the observation that in children, the variation in IGF-I levels is almost completely under genetic control (27). In elderly adults, however, the contribution of genetic factors to the regulation of IGF-I concentrations is much lower (10, 11). Aging is associated with a progressive increase in somatostatinergic tone (32), which is likely to be at least in part responsible for large decreases in both GH and IGF-I secretions (33, 34, 35). The relative influence on GH secretion of environmental factors such as nutrition and physical exercise could increase with aging, leading to a modulation of the expression of genetic control.

Despite the fact that multiple nongenetic factors are known to markedly affect human GH secretion, including nutritional status, stress, levels of physical activity, and sleep quality, the present study clearly demonstrates that genetic factors play an important role in determining the amount of pulsatile GH secreted in normal young adults during the daytime and, to a lesser extent, during the entire 24-h cycle.


    Acknowledgments
 
We thank Dirk Andries for assistance with subject recruitment, Anne Vanonderbergen, M.D., for assistance with the management of clinical studies, Jean-Pol Lanquart, Ph.D., for help with data management, and Prof. J. C. Christian for making the software for analysis of genetic variance available.


    Footnotes
 
1 This work was supported in part by a grant from the Belgian Fonds de la Recherche Scientifique Médicale (Brussels, Belgium), the Association for the Study of Mental Health, the Association Nationale D’Aide Aux Handicapés, the Association of the Belgian Rotary Club, and Grants DK-41814 and AG-11412 from the NIH (Bethesda, MD). Back

Received August 5, 1998.

Revised November 23, 1998.

Accepted December 11, 1998.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Thorner M, Vance M, Horvath E, Kovacs K. 1991 The anterior pituitary. In: Wilson J, Foster D, eds. Williams’ textbook of endocrinology. Philadelphia: Saunders; 221–230.
  2. Smith RG, Van der Ploeg LXT, Howard AD, et al. 1997 Peptidomimergic regulation of growth hormone secretion. Endocr Rev. 18:621–645.[Abstract/Free Full Text]
  3. Takahashi Y, Kipnis DM, Daughaday WH. 1968 Growth hormone secretion during sleep. J Clin Invest. 47:2079–2090.
  4. Sassin JF, Parker DC, Mace JW, Gotlin RW, Johnson LC, Rossman LG. 1969 Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science. 165:513–515.[Abstract/Free Full Text]
  5. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G. 1992 A quantitative estimation of GH secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab. 74:1441–1450.[Abstract]
  6. Van Cauter E, Plat L, Copinschi G. 1998 Interrelations between sleep and the somatotropic axis. Sleep. 21:553–566.[Medline]
  7. Meikle AW, Stringham JD, Woodward MG, Bishop DT. 1988 Heritability of variation of plasma cortisol levels. Metabolism. 37:514–517.[CrossRef][Medline]
  8. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E. 1993 Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol. 264:E173–E181.
  9. Parker D, Rossman L. 1974 Sleep-wake cycle, and human growth hormone, prolactin and luteinizing hormone. In: Raiti S, eds. Advances in human growth hormone research. Bethesda: DHEW Publications (NIH); 294–312.
  10. Harrela M, Koistinen H, Kaprio J, et al. 1996 Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 98:2612–2615.[Medline]
  11. Hong Y, Pedersen N, Brismar K, Hall K, de Faire U. 1996 Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab. 81:1791–1797.[Abstract]
  12. Avela K, Lipsanen-Nyman M, Perheentupa J, et al. 1997 Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis. Am J Hum Genet. 60:896–902.[Medline]
  13. Petersenn S, Rasch A, Heyens M, Schulte H. 1998 Structure and regulation of the human growth hormone-releasing hormone receptor gene. Mol Endocrinol. 12:233–247.[Abstract/Free Full Text]
  14. Gertner J, Wajnrajch M, Leibel R. 1998 Genetic defects in the control of growth hormone secretion. Horm Res. 49(Suppl 1):9–14.
  15. Linkowski P, Kerkhofs M, Hauspie R, Susanne C, Mendlewicz J. 1989 EEG sleep patterns in man: a twin study. Electroenceph Clin Neurophysiol. 73:279–284.[CrossRef][Medline]
  16. Virasoro E, Copinschi G, Bruno OD, Leclercq R. 1971 Radioimmunoassay of human growth hormone using a charcoal-dextran separation procedure. Clin Chim Acta. 31:294–297.[CrossRef][Medline]
  17. Van Cauter E. 1988 Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol. 254:E786–E794.
  18. Faria ACS, Veldhuis JD, Thorner MO, Vance ML. 1989 Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone, and suppression with somatostatin. J Clin Endocrinol Metab. 68:535–541.[Abstract/Free Full Text]
  19. Rechtschaffen A, Kales A. 1968 A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington DC: U.S. Government Printing Office.
  20. Christian JC, Kang KW, Norton JAJ. 1974 Choice of an estimate of genetic variance from twin data. Am J Hum Genet. 26:154–161.[Medline]
  21. Christian JC, Borhani WP, Castelli R, et al. 1987 Plasma cholesterol variation in the National Heart, Lung and Blood Institute Twin Study. Genet Epidemiol. 4:433–446.[CrossRef][Medline]
  22. Christian JC, Li T-K, Norton JAJ, Propping P, Yu P-L. 1988 Alcohol effects on the percentage of beta waves in the electroencephalograms of twins. Gen Epidemiol. 5:217–224.
  23. Williams CJ, Christian JC, Norton JAJ. 1992 TWINAN90: a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Technical Report 92–01, Division of Statistics, Indiana University School of Medicine.
  24. Grubbs FE. 1969 Procedures for detecting outlying observations in samples. Technometrics. 11:1–21.
  25. Grubbs FE, Beck G. 1972 Extension of sample sizes and percentage points for significance tests of outlying observations. Technometrics. 14:847–854.[CrossRef]
  26. Eaves LJ. 1988 Dominance alone is not enough. Behav Genet. 1:27–33.
  27. Kao P, Matheny AJ, Lang C. 1994 Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab. 78:310–312.[Abstract]
  28. Furlanetto RW, Underwood LE, Van Wyk JJ, D’Ercole AJ. 1977 Estimation of somatomedin-C levels in normals and patients with pituitary disease by radio-immunoassay. J Clin Invest. 60:648–657.
  29. Ullrich A, Berman C, Dull T, Gray A, Lee J. 1984 Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe. EMBO J. 3:361–364.[Medline]
  30. Cooke N. 1994 Prolactin: basic physiology. In: DeGroot LJ, eds. Endocrine, and other biological rhythms. Philadelphia: Saunders; 368–393.
  31. Linkowski P, Spiegel K, Kerkhofs M, et al. 1998 Genetic and environmental influences on prolactin secretion during wake and during sleep. Am J Physiol. 274:E909–E919.
  32. Muller EE, Cella SG, Parenti M, et al. 1995 Somatotropic dysregulation in old mammals. Horm Res. 43:39–45.[Medline]
  33. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51–58.[Abstract/Free Full Text]
  34. van Coevorden A, Mockel J, Laurent E, et al. 1991 Neuroendocrine rhythms and sleep in aging. Am J Physiol. 260:E651–E661.
  35. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf). 41:351–357.[Medline]



This article has been cited by other articles:


Home page
Hum ReprodHome page
E.A.M. Kuijper, C.B. Lambalk, D.I. Boomsma, S. van der Sluis, M.A. Blankenstein, E.J.C. de Geus, and D. Posthuma
Heritability of reproductive hormones in adult male twins
Hum. Reprod., August 1, 2007; 22(8): 2153 - 2159.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, B. Burwinkel, P. Bugert, R. K. Schmutzler, B. Wappenschmidt, D. Butkiewicz, J. Pamula, et al.
Polymorphisms in genes involved in GH1 release and their association with breast cancer risk
Carcinogenesis, September 1, 2006; 27(9): 1867 - 1875.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
K Wagner, K Hemminki, E Israelsson, E Grzybowska, R Klaes, B Chen, D Butkiewicz, J Pamula, W Pekala, and A Forsti
Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 917 - 928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
N. L. Anderson and N. G. Anderson
The Human Plasma Proteome: History, Character, and Diagnostic Prospects
Mol. Cell. Proteomics, November 1, 2002; 1(11): 845 - 867.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendlewicz, J.
Right arrow Articles by Van Cauter, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendlewicz, J.
Right arrow Articles by Van Cauter, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals